Fatty acid metabolism pathway enzyme

Fatty acid metabolism pathway enzymes encompass a diverse group of metabolic enzymes crucial for the synthesis, breakdown, and regulation of fatty acids. These enzymes are central to key biological functions including energy production, lipid storage, cellular signaling, and the biosynthesis of bioactive lipids. Dysregulation of fatty acid metabolism enzymes is implicated in a wide range of diseases, such as metabolic syndrome, obesity, diabetes, cancer, cardiovascular disease, neurodegenerative diseases, and inflammation. Consequently, these enzymes are considered therapeutic targets, with various drugs interacting to modulate their activity or expression, including inhibitors of fatty acid synthesis (e.g., orlistat) or oxidation (e.g., etomoxir), and transcriptional regulators (e.g., PPAR agonists). Monitoring biomarkers like acylcarnitine profiles and specific enzyme activity can aid in patient selection and efficacy tracking. Notable safety concerns with drugs targeting these pathways can include hepatotoxicity.

Other names

Fatty acid metabolic enzymesenzymes involved in fatty acid metabolismlipid metabolism enzymes

Inhibition of fatty acid oxidation (by targeting CPT1, e.g., etomoxir); Inhibition of fatty acid synthesis (by targeting ACC or FAS, e.g., orlistat); Activation of transcriptional regulators (e.g., PPAR agonists upregulate enzymes involved); Modulation of enzyme activity or gene expression